Altimmune Inc.

09/24/2021 | Press release | Distributed by Public on 09/24/2021 15:27

Submission of Matters to a Vote of Security Holders (Form 8-K)

Submission of Matters to a Vote of Security Holders.

On September 23, 2021, Altimmune, Inc. (the "Company") held its 2021 Annual Meeting of Stockholders (the "2021 Annual Meeting"). As of August 10, 2021, the record date for the 2021 Annual Meeting, there were 39,705,884 shares of the Company's common stock outstanding and entitled to vote at the 2021 Annual Meeting. A total of 28,489,957 shares of common stock were present or represented by proxy at the 2021 Annual Meeting, representing 71.75% of the issued and outstanding shares entitled to vote at the meeting, representing a quorum. The proposals voted upon and the final results of the vote were as follows:

Proposal No. 1: Election of Directors. The results were as follows:

Director For Withhold Broker
Non-Votes
Mitchel Sayare, Ph.D. 18,420,433 392,066 9,677,458
Vipin K. Garg, Ph.D. 18,417,793 394,706 9,677,458
David J. Drutz, M.D. 15,118,630 3,693,869 9,677,458
John M. Gill 11,033,020 7,779,479 9,677,458
Philip L. Hodges 18,400,560 411,939 9,677,458
Diane Jorkasky, M.D. 18,406,747 405,752 9,677,458
Wayne Pisano 14,848,010 3,964,489 9,677,458
Klaus O. Schafer, M.D., MPH 18,400,808 411,691 9,677,458

Proposal No. 2: Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2021. The results were as follows:

For Against Abstain
28,430,498 29,266 30,193

Proposal No. 3: Advisory vote on the Compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the SEC's compensation rules (referred to as the "say-on-pay" proposal). The results were as follows:

For Against Abstain Broker Non-Votes
8,321,213 10,439,681 51,605 9,677,458

Proposal No. 4: Vote to authorize the adjournment of the 2021 Annual Meeting to enable the Board of Directors to solicit additional proxies. The results were as follows:

For Against Abstain
18,509,254 9,785,811 194,892